L’Hypertension Pulmonaire Post-Embolique (HPPE) est une maladie rare et grave résultant d'une obstruction mécanique progressive des artères pulmonaires provoquant une augmentation progressive de la PAPm (>25 mmHg). Cette pathologie a un traitement chirurgical, l’endartériectomie pulmonaire. Bien que cette maladie ait un traitement, les mécanismes qui impliquent la formation et la persistance de thrombus conduisant à un remodelage vasculaire fibreux, restent à ce jour inconnus. La pathogénèse de l’HPPE présente de grandes similitudes avec celles de l’HTAPi.Ce travail a pu mettre en évidence le phénotype anomal de la cellule endothéliale provenant de séquestres de patients ayant une HPPE ainsi que les anomalies moléculaires à l’origine de cet...
Derivation and characterisation of endothelial cells from patients with chronic thromboembolic pulmo...
Chronic thromboembolic pulmonary hypertension (CTEPH) is a rare, progressive pulmonary vascular dise...
Dysfunctional endothelial cells in patients with chronic thromboembolic pulmonary hypertension Rati...
Pulmonary hypertension (PH) is a rare but disabling disorder, characterised by raised pulmonary arte...
Pulmonary arterial hypertension (PAH) is a severe disease characterized by progressive obstruction o...
International audienceChronic thromboembolic pulmonary hypertension results from chronic mechanical ...
Pulmonary hypertension (PH) is a condition of increased blood pressure within the arteries of the lu...
Pulmonary hypertension (PH) is a condition of increased blood pressure within the arteries of the lu...
Rationale: Dysfunction of endothelial cells is believed to be involved in the development of chronic...
<p>The material obtained from pulmonary endarterectomy (PEA) offers the unique opportunity to study ...
<p>The material obtained from pulmonary endarterectomy (PEA) offers the unique opportunity to study ...
The material obtained from pulmonary endarterectomy (PEA) offers the unique opportunity to study the...
The material obtained from pulmonary endarterectomy (PEA) offers the unique opportunity to study the...
The pathophysiology of pulmonary hypertension (PH) remains unclear. Différent mechanisms are involve...
The pathophysiology of pulmonary hypertension (PH) remains unclear. Différent mechanisms are involve...
Derivation and characterisation of endothelial cells from patients with chronic thromboembolic pulmo...
Chronic thromboembolic pulmonary hypertension (CTEPH) is a rare, progressive pulmonary vascular dise...
Dysfunctional endothelial cells in patients with chronic thromboembolic pulmonary hypertension Rati...
Pulmonary hypertension (PH) is a rare but disabling disorder, characterised by raised pulmonary arte...
Pulmonary arterial hypertension (PAH) is a severe disease characterized by progressive obstruction o...
International audienceChronic thromboembolic pulmonary hypertension results from chronic mechanical ...
Pulmonary hypertension (PH) is a condition of increased blood pressure within the arteries of the lu...
Pulmonary hypertension (PH) is a condition of increased blood pressure within the arteries of the lu...
Rationale: Dysfunction of endothelial cells is believed to be involved in the development of chronic...
<p>The material obtained from pulmonary endarterectomy (PEA) offers the unique opportunity to study ...
<p>The material obtained from pulmonary endarterectomy (PEA) offers the unique opportunity to study ...
The material obtained from pulmonary endarterectomy (PEA) offers the unique opportunity to study the...
The material obtained from pulmonary endarterectomy (PEA) offers the unique opportunity to study the...
The pathophysiology of pulmonary hypertension (PH) remains unclear. Différent mechanisms are involve...
The pathophysiology of pulmonary hypertension (PH) remains unclear. Différent mechanisms are involve...
Derivation and characterisation of endothelial cells from patients with chronic thromboembolic pulmo...
Chronic thromboembolic pulmonary hypertension (CTEPH) is a rare, progressive pulmonary vascular dise...
Dysfunctional endothelial cells in patients with chronic thromboembolic pulmonary hypertension Rati...